跳至主要内容
临床试验/NCT02318433
NCT02318433已完成早期 1 期

Intra-Articular Dexamethasone to Prevent Post-Traumatic Osteoarthritis: A Pilot Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2014年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
Mayo Clinic
入组人数
43
试验地点
1
主要终点
PTOA incidence

研究概览

简要总结

The primary aim of the study is to see if a single wrist injection (intra-articular) of dexamethasone at the time of treatment will reduce the incidence of early-onset of post traumatic osteoarthritis.

详细描述

Our hypothesis is that the intra-articular administration of dexamethasone soon after joint injury will prevent the subsequent development of PTOA, and restore normal joint homeostasis. We plan to generate the data needed to test this hypothesis in a Phase 0 (pilot) clinical trial using patients who have suffered distal radius fractures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Unstable distal radius fracture
  • Fracture type AO B1, B2, B3, C1, C2 or C
  • 18-65 years old
  • Understand and read English
  • Community dwelling (not in assisted living or NH)
  • Exclusion criteria:
  • Open or bilateral DRF
  • Associated upper extremity carpal fracture or carpal ligament injuries requiring casting or surgical repair at the time of DRF fixation.
  • Greater than 2 weeks post injury
  • Neurologic disorders affecting the hand, wrist or arm.
  • History of permanent dementia, Alzheimer's or other neurologic dx
  • Substance abuse
  • Pathologic fractures
  • Known pregnancy
  • Radiocarpal joint arthritis

排除标准

  • 未提供

研究组 & 干预措施

Dexamethasone

Experimental

Subjects receive dexamethasone (4 mg) injection within the radiocarpal joint either in clinic or in the OR.

干预措施: Dexamethasone (Drug)

Saline

Placebo Comparator

Subjects receive sterile saline (4 mg) injection within the radiocarpal joint either in clinic or in the OR.

干预措施: Saline (Drug)

结局指标

主要结局

PTOA incidence

时间窗: 3 years

Primary outcome measure will incidence of post-traumatic osteoarthritis, determined by joint space narrowing, as measured radiologically.

次要结局

  • Patient-rated evaluations(3 years)
  • Functional assessment(3 years)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanjeev (Sanj) Kakar, M.D., M.B.A.

PI

Mayo Clinic

研究点 (1)

Loading locations...

相似试验